Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Atuveciclib (Racemate)

Atuveciclib Racemate (BAY-1143572 Racemate) is the racemate mixture of Atuveciclib. Atuveciclib is a potent and highly selective, oral P-TEFb/CDK9 inhibitor which supresses CDK9/CycT1 with an IC50 of 13 nM.

Product Specifications

CAS Number

1414943-88-6

Product Name Alternative

BAY-1143572 (Racemate)

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

CDK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/BAY-1143572-Racemate.html

Concentration

10mM

Purity

98.48

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

N=S(CC1=CC(NC2=NC(C3=CC=C(F)C=C3OC)=NC=N2)=CC=C1)(C)=O

Molecular Formula

C18H18FN5O2S

Molecular Weight

387.43

Precautions

H302, H315, H319, H335

References & Citations

[1]Scholz A, et al. BAY 1143572, a first-in-class, highly selective, potent and orally available inhibitor of PTEFb/CDK9 currently in Phase I, shows convincing anti-tumor activity in preclinical models of acute myeloid leukemia (AML) . [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA) : AACR; Cancer Res 2016;76 (14 Suppl) :Abstract nr 3022.|[2]Scholz A, et al. BAY 1143572: A first-in-class, highly selective, potent and orally available inhibitor of PTEFb/CDK9 currently in Phase I, inhibits MYC and shows convincing anti-tumor activity in multiple xenograft models by the induction of apoptosis. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA) : AACR; Cancer Res 2015;75 (15 Suppl) :Abstract nr DDT02-02. doi:10.1158/1538-7445.AM2015-DDT02-02

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

CDK9

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

DDI2 CRISPR/Cas9 KO Plasmid (h)
sc-408297 20 µg

DDI2 CRISPR/Cas9 KO Plasmid (h)

Sign In for Pricing
View Details
RAD26, ID (RAD26L, C9orf102, Putative DNA repair and recombination protein RAD26-like) (MaxLight 405) discontinued
040795-ML405 100 µL

RAD26, ID (RAD26L, C9orf102, Putative DNA repair and recombination protein RAD26-like) (MaxLight 405) discontinued

Sign In for Pricing
View Details
NSC-109555 Ditosylate
562110 10.0mg

NSC-109555 Ditosylate

Sign In for Pricing
View Details
Anti-Human LMOD3 Polyclonal Antibody
HC644014-01 50 µg

Anti-Human LMOD3 Polyclonal Antibody

Sign In for Pricing
View Details
Anti-Human LMOD3 Polyclonal Antibody
HC644014-02 100 µg

Anti-Human LMOD3 Polyclonal Antibody

Sign In for Pricing
View Details
MEM contains Earle's salt, is free of L-glutamide and phenolic red is free of non-essential amino acids
M3411 500 mL

MEM contains Earle's salt, is free of L-glutamide and phenolic red is free of non-essential amino acids

Sign In for Pricing
View Details